Go to the id21 home page   ID21 - communicating development research
Health
 
Search the whole id21 database
 

Help page and other search methods
    id21 Health
  Health systems
and economics
  Non-communicable
diseases
  Infectious
diseases
  HIV/AIDS
  Sexual and
reproductive health
  Maternal health
  Child health
  Environmental
health
 
    id21 Global Issues
 
    id21 Education
 
    id21 Urban Development
 
    id21 Natural Resources
 
    id21 Rural Development
 
    id21 Home page
 
    Gender and Violence in African Schools
 
    id21 Publications
 
    id21 Viewpoints
 
    About id21
 
    Links
 
    Contact id21
 
    id21News
 
    id21 Insights
 
    id21 Media
 
     
Counting the cost of HIV in Southern Africa

Southern Africa is the region with the highest rates of HIV infection in the world. An estimated 9.4 million of the total population of 97 million were HIV-positive in 1999. What impact will the HIV/AIDS epidemic have on the provision of health services in the region? Is there any scope for improving access to highly active antiretroviral therapy (HAART) in low-income countries?

A study by the International Monetary Fund warns that health services in southern Africa are already over-stretched. The current cost of providing health services to HIV patients accounts for a very large proportion of total health expenditure for most countries in the region. As the number of AIDS patients increases, the situation will deteriorate.

The ability of the health sector to cope with the HIV/AIDS epidemic depends on the availability of staff, facilities and finance. The total health expenditure per capita ranges from US$ 9 in Malawi to US$ 203 in South Africa. This corresponds to between 0.2 percent and 4.1 percent of per capita health spending in the United States. Other important findings include:

  • Physicians are extremely scarce in some parts of the region. In Malawi and Mozambique there are as few as three doctors per 100,000 people.
  • Health workers are also affected by HIV/AIDS. Training would have to be expanded by about 25 to 40 percent over the next decade just to maintain current staff levels.
  • A significant proportion of the population in these countries does not have easy access to the most basic medications for AIDS-related diseases.
  • There is little public health insurance. For six of the eleven economies covered, private health insurance accounts for less than 10 percent of private health expenditure.
  • The number of hospital beds needed for AIDS patients will exceed the total currently available in Botswana by 2002, in Swaziland by 2004 and in Namibia by 2005.
  • Owing to substantial reductions in the price of antiretrovirals, Botswana and South Africa could provide HAART to a significant proportion of AIDS patients. However, the prospects for other countries are very limited.

The HIV/AIDS epidemic is already a huge burden on the health sector in southern Africa. As more people living with HIV are expected to fall ill over the next decade, the situation is likely to become even worse. Maintaining the quality of health services will require substantial investments in health facilities and human resources, which will be impossible without significant external aid. Policy-makers addressing the impact of the disease on countries with few resources should consider:

  • negotiating reductions in drug prices - a cost of around $500 per patient per year would greatly increase the number of those who can afford to pay for treatment
  • expanding the scope of private health insurance
  • providing external assistance to build the necessary health infrastructure and train the required personnel.

Source(s):
‘Providing health care to HIV patients in southern Africa’ by Markus Haacker, presented to the Royal Institute for International Affairs, London (10th July, 2001) and forthcoming in 'The economics of essential medicines', RIIA Full document.
Related source: 'The economic consequences of HIV/AIDS in Southern Africa', IMF Working Paper 02/38, by M. Haacker, 2002 Full document.

Funded by: International Monetary Fund

id21 Research Highlight: 4 April 2002

Further Information:
Markus Haacker
Room 8-515
International Monetary Fund
700 19th St NW
Washington DC
USA

Tel: +1 202 623 4089
Fax: +1 202 589 4089
Contact the contributor: mhaacker@imf.org

International Monetary Fund

Other related links:
See id21's collection of links relevant to HIV/AIDS...

...and health economics.

Follow id21's email discussion on access to HIV treatment online.

Views expressed on these pages are not necessarily those of DFID, IDS, id21 or other contributing institutions. Unless stated otherwise articles may be copied or quoted without restriction, provided id21 and originating author(s) and institution(s) are acknowledged.

Copyright © 2007 id21. All rights reserved.

Week beginning Monday 18th August 2008
FREE Information Delivery services from id21:
Get updates by email: id21 news
Insights: research digests
Contact id21


id21 is funded by the UK Department for International Development www.dfid.gov.uk
id21 is one of a family of knowledge services at the Institute of Development Studies www.ids.ac.uk at the University of Sussex www.sussex.ac.uk
IDS is a charitable company, No. 877338. id21 is a www.oneworld.net partner and an affiliate of
www.mediachannel.org

 

 

Go to the International Monetary Fund site.